Skip to main content

Analysts say Boston Scientific faces 'higher level of exposure' to risk

Boston Scientific Corp. is expected to report its Q3 earnings on Wednesday, and the medical device manufacturer is widely expected to post year-over-year growth as it works to bounce back from last year's Covid-19-driven hit.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.